Apellis Pharmacueticals
biopharmaceutical company that develops therapies for hematology, ophthalmology, etc.
Based in MA
AI Overview
With $200K in lobbying spend across 13 quarterly filings, Apellis Pharmacueticals is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $0 |
| 2021 | $80K |
| 2022 | $80K |
| 2023 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Apellis Pharmacueticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, MED
Medicare reimbursement , Cell and Gene therapy research
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.